4 research departments
750 employees
45 nationalities
55 research teams
16 ERC laureates
260 publications per year
24000 m² lab area

Support us through

Fondation universite de Strasbourg

photo

Head

Key figures

52 research teams
127 researchers
34 post-doctoral fellows
31 PhD students
109 engineers & technicians
110 administrators & general services 110 ICS employees

Quick Links

Job opportunities

Post-Doctoral Position To Study Rna Decay In The Context Of Cancer, Séraphin Lab

Reference : IGBMC-POD-43

Offer publication : Aug. 9, 2021

The applicant will benefit from a highly collaborative and international environment at IGBMC (>700 researchers, 4 departments, 44 teams). The Séraphin team is a leader in the field of eukaryotic RNA decay, RNA processing and protein complex analyses using mammalian and yeast model systems. IGBMC provides access to state-of-the-art platforms and technical support including imaging, proteomic, high throughput sequencing, cell culture, bioinformatics, and mouse facilities. The project will benefit from technical support and develop in the framework of national collaborations. IGBMC is located in the periphery of Strasbourg providing a scientifically and culturally rich and unique environment.

Assignments

The Séraphin team working on protein complexes involved in RNA decay is hiring a post-doc (24 months with possibility of extension) to work onthe Exploration of the role of RNA decay in cancer

Activity

The importance of mRNA decay in regulating and finely tuning gene expression is now well established. Recent evidences link defects in RNA decay with human cancer such as in the mutations of DIS3, encoding a catalytic subunit of the nuclear exosome complex involved in the degradation of RNA, in multiple myeloma.

The project, developed as part of a multidisciplinary consortium, will investigate the impact of mutations in defined RNA decay factors in cancer. Based on genetic and genomic information, as well as clinical and epidemiological data, the successful candidate will develop and analyze animal models to study therole of RNA decay in cancer. Molecular and cellular analyses will be performed using cutting-edge technologies including transcriptome analyses, cell and tissue phenotyping, proteomic, and imaging… and build on medical data collected in parallel by partner teams. This project will determine whether alterations in some RNA decay factors have an impact on the prognosis of patients, which could justify specific treatment. Moreover, a better understanding of the role of such alterations could thus have repercussions in other types of cancer.

Profile

We are looking for a highly motivated and experienced candidate with strong expertise in use of animal model for the study of cancer. Additional experience in transcriptomics and genome-wide data analyses would be a plus. Ability to work independently within a team environment, computer literacy and good communication skills are required. Applications are invited for 2 years with possibilities of extensions, starting at the earliest in October, 2021.

Required skills and abilities

Languages

English: good level

French speaking is NOT a requirement

 

Requirements

PhD with expertise in use of animal models, cancer and/or molecular biology

Job specifications

Benefits

Salary based on experience following Institute guidelines

Your application

Please send your application including a statement describing research experience and expertise as well as future research interests, a curriculum vitae with publication list, date of availability, and at least two contacts for references (including phone number and email) to seraphin(at)igbmc.fr.

Imprimer Envoyer

Université de Strasbourg
INSERM
CNRS

IGBMC - CNRS UMR 7104 - Inserm U 1258
1 rue Laurent Fries / BP 10142 / 67404 Illkirch CEDEX / France Tél +33 (0)3 88 65 32 00 / Fax +33 (0)3 88 65 32 01 / directeur.igbmc@igbmc.fr